Also Known As
This article was last reviewed on
This article waslast modified on March 25, 2021.
At a Glance
Why Get Tested?

Primarily to monitor cancer treatment, including response to therapy and recurrence; as an indicator of the amount of cancer or size of tumor present (tumor burden) and to assist in cancer staging; occasionally as follow up to a positive screening test for cancer, to compare whether the level falls to normal (indicating that the cancer was all likely removed) after treatment for the cancer

When To Get Tested?

When you have been diagnosed with colon, pancreas, breast, lung, ovarian, medullary thyroid or other cancer prior to starting cancer treatment and then, if elevated, at intervals during and after therapy; occasionally when cancer is suspected but not confirmed – to aid in its detection

Sample Required?

A blood sample is taken by needle from a vein in the arm. Occasionally, another body fluid such as peritoneal fluid, pleural fluid, or cerebrospinal (CSF) is collected by a healthcare practitioner for testing.

Test Preparation Needed?


You may be able to find your test results on your laboratory's website or patient portal. However, you are currently at Lab Tests Online. You may have been directed here by your lab's website in order to provide you with background information about the test(s) you had performed. You will need to return to your lab's website or portal, or contact your healthcare practitioner in order to obtain your test results.

Lab Tests Online is an award-winning patient education website offering information on laboratory tests. The content on the site, which has been reviewed by laboratory scientists and other medical professionals, provides general explanations of what results might mean for each test listed on the site, such as what a high or low value might suggest to your healthcare practitioner about your health or medical condition.

The reference ranges for your tests can be found on your laboratory report. They are typically found to the right of your results.

If you do not have your lab report, consult your healthcare provider or the laboratory that performed the test(s) to obtain the reference range.

Laboratory test results are not meaningful by themselves. Their meaning comes from comparison to reference ranges. Reference ranges are the values expected for a healthy person. They are sometimes called "normal" values. By comparing your test results with reference values, you and your healthcare provider can see if any of your test results fall outside the range of expected values. Values that are outside expected ranges can provide clues to help identify possible conditions or diseases.

While accuracy of laboratory testing has significantly evolved over the past few decades, some lab-to-lab variability can occur due to differences in testing equipment, chemical reagents, and techniques. This is a reason why so few reference ranges are provided on this site. It is important to know that you must use the range supplied by the laboratory that performed your test to evaluate whether your results are "within normal limits."

For more information, please read the article Reference Ranges and What They Mean.

What is being tested?

Carcinoembryonic antigen (CEA) is a protein that is present in certain tissues of a developing baby (fetus). By the time a baby is born, it drops to a very low level. In adults, CEA is normally present at very low levels in the blood but may be elevated with certain types of cancer. This test measures the amount of CEA in the blood to help evaluate individuals diagnosed with cancer.

CEA is a tumor marker. Originally, it was thought that CEA was a specific marker for colon cancer, but further study has shown that an increase in CEA may be seen in a wide variety of other cancers. CEA can also be increased in some non-cancer-related conditions, such as inflammation, cirrhosis, peptic ulcer, ulcerative colitis, rectal polyps, emphysema, and benign breast disease, and in smokers. For this reason, it is not useful as a general cancer screening tool, but it does have a role in evaluating response to cancer treatment. When you have been diagnosed with cancer, an initial baseline test for CEA may be performed. If this level is elevated, then subsequent serial testing of CEA may be performed to monitor the cancer during treatment.

Accordion Title
Common Questions
  • How is the test used?

    The carcinoembryonic antigen (CEA) test may be used:

    • To monitor the treatment of colon cancer—it may also be used as a marker for medullary thyroid cancer and cancers of the rectum, lung, breast, liver, pancreas, stomach, and ovaries. An initial CEA test is typically ordered prior to treatment, such as chemotherapy or radiation therapy, as a "baseline" value. If the level is elevated, then the test can be used to monitor a person's response to therapy and to determine whether the cancer has returned after treatment.
    • To stage cancer—cancer staging involves evaluating the size of the tumor as well as how far it has spread.
    • To help determine if cancer has spread to a body cavity such as the chest or abdomen by measuring the CEA level in a body fluid (e.g., pleural or peritoneal fluid).

    A CEA test may be used in combination with other tumor markers in the evaluation of cancer.

    Not all cancers produce CEA, and a positive CEA test is not always due to cancer. Therefore, CEA is not recommended for screening the general population.

  • When is it ordered?

    A CEA test may be ordered when you have been diagnosed with colon cancer or other specific type of cancer. It will be measured before therapy is initiated and then on a regular basis to evaluate the success of treatment and to determine whether the cancer has come back after treatment (recurrence).

    Sometimes a CEA test may be performed when cancer is suspected but not yet diagnosed. This is not a common use for the test because CEA can be elevated with many conditions, but it may provide a healthcare practitioner with additional information.

    A CEA test may sometimes be performed on a fluid other than blood when a healthcare practitioner suspects that a cancer has metastasized (e.g., spread to the pleural or peritoneal cavity).

  • What does the test result mean?

    For treatment, recurrence monitoring:
    When CEA levels are initially elevated and then decrease to normal after therapy, it means the cancer has been successfully treated. A steadily rising CEA level is often the first sign of tumor recurrence.

    For staging:
    On initial testing, people with smaller and early-stage tumors are likely to have a normal or only slightly elevated CEA value. People with larger tumors, later-stage cancer, or tumors that have spread throughout the body are more likely to have a high CEA value.

    Testing for metastasis:
    If CEA is present in a body fluid other than blood, then cancer is likely to have spread into that area of the body. For example, if CEA is detected in cerebrospinal fluid, this may indicate that cancer has spread to the central nervous system.

    Since not all cancers produce CEA, it is possible to have cancer but also have a normal CEA. If a cancer does not produce CEA, then the test will not be useful as a monitoring tool.

  • If I am a smoker, does an elevated CEA level mean I have cancer?

    Not necessarily. Smokers can have CEA values up to twice the normal range for non-smokers and not have cancer.

  • Will every person with cancer have a CEA test performed?

    No. CEA has a role to play in certain tumors, particularly colon cancer. However, a number of other tumor markers have been developed to monitor cancers from different areas of the body. As an example, breast cancer is usually monitored with a CA 15-3 test or a CA 27.29 test. For some cancers, testing for tumor markers is not done at all.

  • Are there any side effects of performing a CEA test?

    A CEA blood test typically has no associated risk. Very mild pain and bruising may occur at the site where blood was collected using a needle. To assess metastasis, fluid can be collected from other sites. For example, pleural fluid may be collected from the area surrounding the lungs. This procedure has a small risk of lung injury, bleeding, or infection. When peritoneal fluid (the liquid in the abdomen filling the sacs surrounding the intestine) is collected to assess abdominal metastasis, there may be a small risk of damage to the intestine or other organs. You may also feel pain and dizziness after the procedure. To assess brain metastasis, CSF will be collected by a spinal tap (lumbar puncture) to measure the CEA. With this procedure, back pain or tenderness at the needle insertion might happen, and a post lumbar headache or dizziness might occur.

  • Is there anything else I should know?

    Laboratories may use different methods to test for CEA, so results can vary from lab to lab. If you are having a series of CEA tests done, it is advised that you have the tests done by the same method, typically by the same laboratory, so that the results can be compared and interpreted correctly. You may wish to discuss this issue with your healthcare provider.

    Individuals who smoke cigarettes tend to have higher CEA levels than non-smokers.

    Increased CEA levels can indicate some non-cancer-related conditions, such as inflammation, cirrhosis, peptic ulcer, ulcerative colitis, rectal polyps, emphysema, and benign breast disease.

View Sources

Sources Used in Current Review

2020 review performed by Imad Tarhoni, MD, PhD.

Su BB, Shi H, Wan J: Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection. World J Gastroenterol 2012, 18:2121-6.

Hall C, Clarke L, Pal A, Buchwald P, Eglinton T, Wakeman C, Frizelle F: A Review of the Role of Carcinoembryonic Antigen in Clinical Practice. Ann Coloproctol 2019, 35:294-305.

© 1995–2020. Mayo Foundation for Medical Education and Research. Carcinoembryonic Antigen (CEA), Serum. Available online at Accessed May 2020.

Sources Used in Previous Reviews

Clarke, W. and Dufour, D. R., Editors (2006). Contemporary Practice in Clinical Chemistry, AACC Press, Washington, DC. Pp 244-245.

Pagana K, Pagana T. Mosby's Manual of Diagnostic and Laboratory Tests. 3rd Edition, St. Louis: Mosby Elsevier; 2006 pp 161-162.

MedlinePlus Medical Encyclopedia: CEA. Available online at Accessed February 2009.

(Revised 2012 January 20). How is Thyroid Cancer Diagnosed? American Cancer Society [On-line information]. Available online at Accessed October 2012.

Dugdale, D. (Updated 2011 August 5). CEA blood test. MedlinePlus Medical Encyclopedia. [On-line information]. Available online at Accessed October 2012.

(Revised 2012 October 1). How is colorectal cancer diagnosed? American Cancer Society. [On-line information]. Available online at Accessed October 2012.

(© 1995-2012). Carcinoembryonic Antigen (CEA), Serum. Mayo Clinic Mayo Medical Laboratories [On-line information]. Available online at Accessed October 2012.

(Revised 2011 March 24). Common cancers and the tumor markers linked to them. American Cancer Society [On-line information]. Available online through Accessed October 2012.

(Reviewed 2011 December 30). Tests to Detect Colorectal Cancer and Polyps. National Cancer Institute. [On-line information]. Available online at Accessed October 2012.

Pagana, K. D. & Pagana, T. J. (© 2011). Mosby's Diagnostic and Laboratory Test Reference 10th Edition: Mosby, Inc., Saint Louis, MO. Pp 223-224.

Clarke, W., Editor (© 2011). Contemporary Practice in Clinical Chemistry 2nd Edition: AACC Press, Washington, DC. Pp 244-245.

Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Burtis CA, Ashwood ER, Bruns DE, eds. 4th edition, St. Louis: Elsevier Saunders; 2006, Pg 768.

U.S. National Library of Medicine (1 August 2015 updated). CEA Blood Test. Available online at Accessed June 28, 2016.

Penn Medicine Oncolink® (28 April 2016 updated). Patient Guide to Tumor Markers. Available online at Accessed June 28, 2016.

National Cancer Institute (4 November 2015 reviewed). Tumor Markers. Available online at Accessed June 28, 2016.

American Cancer Society (6 March 2014 updated). How Is Advanced Cancer Found? Available online at Accessed June 28, 2016.

Ask a Laboratory Scientist

This form enables patients to ask specific questions about lab tests. Your questions will be answered by a laboratory scientist as part of a voluntary service provided by one of our partners, American Society for Clinical Laboratory Science. Please allow 2-3 business days for an email response from one of the volunteers on the Consumer Information Response Team.

Thank you for using the Consumer Information Response Service (“the Service”) to inquire about the meaning of your lab test result. The Service is provided free of charge by the American Society for Clinical Laboratory Science.

Please note that information provided through this free Service is not intended to be medical advice and should not be relied on as such. Although the laboratory strives to provide the largest single source of objective, scientific data on patient status, it is only one part of a complex biological picture of health or disease. As professional clinical laboratory scientists, our goal is to assist you in understanding the purpose of laboratory tests and the general meaning of your laboratory results. It is important that you communicate with your physician so that together you can integrate the pertinent information, such as age, ethnicity, health history, signs and symptoms, laboratory and other procedures (radiology, endoscopy, etc.) to determine your health status. The information provided through this Service is not intended to substitute for such consultations with your physician nor specific medical advice to your health condition.

By submitting your question to this Service, you agree to release and hold harmless the American Society for Clinical Laboratory Science and its affiliates or their past or present officers, directors, employees, agents and Service volunteers (collectively referred to as “ASCLS”) and Lab Tests, LLC and its affiliates or their past or present members, managers, officers, directors, employees, agents and Service volunteers (collectively referred to as the “LT Parties”) from any legal claims, rights or causes of action you may have relating to or arising out of your use of the Service or in connection with the responses provided to the questions that you submit to the Service.

ASCLS and the LT Parties hereby disclaim any and all liability arising out of your use of this Service or for any adverse outcome from your use of the information provided by this Service for any reason, including but not limited to any misunderstanding or misinterpretation of the information provided through this Service.